CD274 and Sepsis: Intravenous delivery of siRNA targeting PD-L1 expression reduces neutrophil influx into lungs and attenuates sepsis-induced lung injury, indicating targeting PD-L1 as an attractive therapeutic target to protect against sepsis-induced lung injury.